RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - MECCANISMI DI RIPARAZIONE DEL DANNO EPATICO MODULATI DA IGF1 E SUE ISOFORME NELLE MALATTIE CRONICHE DI FEGATO ED IN MODELLI SPERIMENTALI. Sviluppo di strategie terapeutiche basate sulla modulazione del sistema IGF1.
• 2 - Il precondizionamento epatico: meccanismi biomolecolari di induzione della tolleranza al danno da ischemia-riperfusione ed applicazioni cliniche negli interventi di resezione e di trapianto di fegato
• 3 - EICOSANOIDI E MONOSSIDO DI AZOTO NEL DANNO ISCHEMICO CEREBRALE E NELLA RISOLUZIONE DELLA RISPOSTA INFIAMMATORIA AD ESSO ASSOCIATA
• 4 - RUOLO DELLE CELLULE DENDRITICHE, DELLE CITOCHINE E DEGLI ORMONI STEROIDEI SESSUALI NELLA STORIA NATURALE DELLE MALATTIE EPATICHE CRONICHE
• 5 - Studio di nuovi meccanismi molecolari nel controllo della risposta fibrogenica
• 6 - La Poli(ADPR)polimerasi:implicazioni fisiopatologiche per approcci terapeutici innovativi.
• 7 - Meccanismi di danno e protezione nel miocardio ischemico
• 8 - RUOLO DEI RECETTORI ATTIVATI DALLE PROTEASI (PAR)- 1 e 2 NELL'INFIAMMAZIONE ED IN PROCESSI FIBROTICI AD ESSA CORRELATI.
• 9 - RUOLO DELLO STRESS OSSIDATIVO NEI PROCESSI NEUROINFIAMMATORI ASSOCIATI ALL'INFEZIONE DA HIV
• 10 - Biomarkers, espressione genica e modulazione farmacologica in modelli di ipossia-ischemia e di infezione in vitro ed in vivo.

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • ANATOMIA PATOLOGICA
  • GASTROENTEROLOGIA
  • CHIRURGIA GENERALE

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Lazio

Bibliografia

1) Jones JI. Insulin-like growth factors and their binding proteins. Endocr Rev 1995; 16:3-34.
2) Sepp-Lorenzino L.. Structure and function of the insulin-like growth factor I receptor. Breast Cancer Res Treat 1998;47:235-253.
3) Butler AA. Minireview: tissue-specific versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology. Endocrinology 2001; 142:1685-1688.
4) Giustina A. Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human. Endocrine Reviews 1998; 19: 717-797.
5) Lupu F, et al. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 2001;229:141-162.
6) Wang J, et al.. Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol 2004;180:247-255.
7) Musarò A, et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nature Genet 27:195-200,2001.
8) Hameed M, et al. J Physiol 547:247-254,2003.
9) McCall GE, et al. Trancriptional regulation of IGF-I expression in skeletal muscle. Am J Cell Physiol 285:831-839,2003.
10) Wang X, et al. Characterization of the rat insulin-like growth factor I gene promoters and identification of a minimal exon 2 promoter. Endocrinol 1996;134:1528-1536.
11) Pfaffl MW, et al. Domest Anim Endocrinol 22:91-102,2002.
12) Barton ER. et al. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol. 2002;157:137-48.
13) Aperghisa M. et al. Different levels of neuroprotection by two insulin-like growth factor-I splice variants. Brain Research 1009 (2004) 213- 218
14) Musaro, A., and N. Rosenthal. 1999. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. Mol Cell Biol 19:3115-3124.
15) Dobrowolny G, et al. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 2005;168:193-9.
16) Barton-Davis, et al. 1998. PNAS USA 95:15603-15607.
17) Barton-Davis, et al. 1999. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand. 167:301-305.
18) Kaspar, B.K., et al. 2003. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science. 301:839-842.
19) Higuchi H, Gores GJ. Curr Mol Med. 2003 3:483-90.
20) Higuchi H, Gores GJ. Bile acid regulation of hepatic physiology: IV. Bile acids and death receptors.Am J Physiol Gastrointest Liver Physiol. 2003;284:G734-8
21) Desmet V, et al. Histopathology of vanishing bile duct diseases. Adv Clin Path 1998; 2: 87-99.
22) Desmet V, et al. Pathology of the biliary tree in cholestasis: ductular reaction. In: Manns MP, Boyer JL, Jansen PLM, and Reichen J., editors. Cholestatic liver diseases. Kluwer Academic Publishers; 1998;143-154.
23) Alvaro D, et al. Regulation and deregulation of cholangiocyte proliferation. J Hepatol 2000; 33:333-340.
24) Alvaro D. et al. The intrahepatic biliary epithelium is a target of the growth hormone/insulin like growth factor 1 axis. In Press
25) Alvaro D, et al. J Clin Invest 1997;100:1349-1362.
26) Alvaro D, et al. Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. Gastroenterology 2000;119:1681-1691.
27) Alvaro D, et al. Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. Gastroenterology 2002;123:336-344.
28) Gigliozzi A, et al. Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. Gastroenterology 2004;127:1198-1209.
29) Cantafora A, et al. Evaluation of RNA messengers involved in lipid trafficking of human intestinal cells by reverse-transcription polymerase chain reaction with competimer technology and microchip electrophoresis Electrophoresis 2003;24: 3748-3754.
30) Guler HP, et al. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med. 1987;317:137-40
31) Caufriez A, et al. Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis. J Endocrinol Invest. 1991;14:317-21.
32) Picardi A, et al. J Hepatol. 1997;26:191-202.
33) 4)Baruch Y. The liver: a large endocrine gland. J Hepatol. 2000;32:505-7.
34) De Palo EF, et al. GH/IGF system, cirrhosis and liver transplantation. Clin Chim Acta. 2001;310:31-37
35) Rajaram S, et al. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev. 1997;18:801-31.
36) Yakar S, et al. The growth hormone/insulin-like growth factor-I system: implications for organ growth and development. Pediatr Nephrol. 2000l;14:544-9.
37) McElduff A, et al. A comparison of the insulin and insulin-like growth factor I receptors from rat brain and liver. Endocrinology. 1988;122:1933-9.
38) Lamas E, et al.. Hepatology. 1991;13:936-40.
39) Zindy F, et al. Expression of insulin-like growth factor II (IGF-II) and IGF-II, IGF-I and insulin receptors mRNAs in isolated non-parenchymal rat liver cells.J Hepatol. 1992;14:30-4
40) Mohn KL, et al. Mol Cell Biol. 1991;11:1393-401
41) Moller S, et al. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis. J Clin Endocrinol Metab. 1995;80:1148-57
42) Donaghy A, et al. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.Hepatology. 1995;21:680-8.
43) Caregaro L, et al. Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis.Nutrition. 1997;13:185-90
44) Blomsma MC, et al. Insulin-like growth factor-I in liver cirrhosis. J Hepatol. 1997;27:1133-8.
45) Benbassat CA, et al. J Clin Endocrinol Metab. 1997;82:1484-91.
46) Maes M, et al. Growth factors in children with end-stage liver disease before and after liver transplantation: a review. Pediatr Transplant. 1997;1:171-5.
47) Holt RI, et al. The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation.
Pediatr Transplant. 1998;2:76-84.
48) Schalch DS, et al. Serum insulin-like growth factors and their binding proteins in patients with hepatic failure and after liver transplantation. Metabolism.1998;47:200-6.
49) Weber MM, et al. Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation. Horm Res. 2002;57:105-12.
50) Bassanello M, et al. Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: a preliminary prospective study. Liver Transpl. 2004;10:692-8.
51) Delafontaine P, et al. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Art Thromb Vasc Biol 2004;24:435-44.
52) Cohen BD, et al. Clin Cancer Res. 2005;11:2063-73.
53) Lopez-Lopez et al. Insulin-like growth factor I is required for vessel remodeling in the adult brain. PNAS USA. 2004;101:9833-8.
54) Metalli VD, et al. The interaction between insulin like growth factor 1 (IGF-1) and estrogens modulates cholangiocyte proliferation. HEPATOLOGY 36:723,2002.
55) Laurson J, et al. Hepatocyte progenitors in man and in rodents--multiple pathways, multiple candidates. Int J Exp Pathol. 2005;86:1-18.
56) Dabeva MD, Shafritz DA. Hepatic stem cells and liver repopulation. Semin Liver Dis. 2003;23:349-62.
57) Alison MR et al. Update on hepatic stem cells. Liver. 2001;21:367-73
58) Libbrecht L, Roskams T.Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol. 2002;13:389-96.

Parole Chiave

FEGATO; ISOFORME DEL FATTORE DI CRESCITA INSULINO-SIMILE; COLANGIOCITI; EPATOCITI; COLESTASI; VEGF; IMMUNOISTOCHIMICA; BIOLOGIA MOLECOLARE; TRAPIANTO DI FEGATO